Virologic virologic.com


Public lists: Pharma Startups (4732)

Virologic is a biotechnology company that performs, develops and markets drug susceptibility and resistance tests to be used in optimizing the treatment of patients with serious viral infections. Virologic had its IPO in May 2000 (NASDAQ: VLGC).

Virologic is a biotechnology company that performs, develops and markets drug susceptibility and resistance tests to be used in optimizing the treatment of patients with serious viral infections. Virologic had its IPO in May 2000 (NASDAQ: VLGC).

Company (IPO / Went public)

Phone:

Fax:

345 Oyster Point Blvd
South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Virologic $0M Nov 17, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Virologic Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

SpiderBiotech S.r.l.

Italy
Alive / ActiveSpider Biotech is a young and dynamic biotechnology company founded in 2005 with the aim of developing synthetic peptide therapeutics. nnAntimicrobial host-defense peptides have been recognized as an important part of innate immunity found throughout the evolutionary tree that defend against invading bacteria, viruses, and fungi through membrane or metabolic disruption. Inspired by natural antimicrobial peptides, Spider Biotech is developing a library of bioactive peptides and lipopeptides acti...Show allLogin to see details

Transave

Monmouth Junction, New Jersey, United States
MergedTransave is a biotechnology company whose mission is to improve the treatment of serious lung diseases through the development of novel site-specific liposomal drug products. The company's liposomal delivery technology aims to provide for prolonged release of a drug in the lung while minimizing systemic exposure.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)